Ribosomal protein S6 kinase 1 signaling regulates mammalian life span
What this study shows
Deleting S6K1 (a direct mTORC1 effector) extended lifespan in FEMALE mice (+19% median); the effect was not significant in males. It also protected against age-related bone, immune and motor decline. One of the clearest cases of the sex dimorphism catalogued in gap H6 - and a reminder that a single downstream branch, not mTORC1 as a whole, can carry much of the ageing signal.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Mouse (S6K1 knockout)); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Mouse (S6K1 knockout) |
| Journal | Science |
| Year | 2009 |
| Peer reviewed | Yes |
| Record last updated | 2026-07-29 |
| Source | DOI 10.1126/science.1177221 · PMID 19797661 · Free full text (PMC4954603) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genetic (S6K1 knockout) |
| Target | S6K1 / mTOR |
| Model | Mouse (S6K1 KO) |
| Effect | S6K1 deletion extends lifespan in female mice only (+19% median, not significant in males) and improves healthspan measures |
| Dose | not stated |
| Sample size | not stated |
| Effect size | Median lifespan in S6K1 -/- mice increased by 80 days (from 862 to 942 days) or 9% relative to WT mice (X 2 = 10.52, p < 0.001) for both sexes combined. Female S6K1 -/- mice median lifespan increased by 153 days (19%) (p < 0.001), while male S6K1 -/- mice showed no effect (p > 0.05). |
| Limitations | not stated |
In the Atlas
Related topics
Links in the pathway map
- Supports S6K1 inhibits Longevity
Open questions that cite this study
- Cited as supporting evidence for the open question Does the larger rapamycin benefit in female mice survive equal drug exposure, and is it set by hormones or by chromosomes?.
More studies on this topic
- Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans (2007)
- An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline (2026)
- The mTORC1-SLC4A7 axis stimulates bicarbonate import to enhance de novo nucleotide synthesis (2022)
- hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase (2005)
Learn the biology
Want to understand the biology behind this study? → How to Read an mTOR Paper
Thank you. Your answer was counted anonymously.